PXS-5505
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PXS-5505, covering 2025-08-24 to 2026-08-04. Get the full timeline:
Most recent: Clinical Trial Results: Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis [Phase 1, Phase 2]